 |
Ivermectin can “kill cancer cells” and boost immune response, suggest health experts
Ivermectin was used as an alternative treatment amid the Wuhan coronavirus (COVID-19) pandemic, and now researchers are saying that the drug can also help fight cancer by boosting immune response.Rick Alderson, a retired sawmill worker, was diagnosed with terminal colon cancer in November 2020. He endured agonizing pain in his bowels for months. After a consultation, a gastroenterologist discovered a large tumor in his rectum. Alderson and his wife were told that he only had six months to live.
Eve Alderson, Rick’s wife, said that his oncologist saw him as “a dead man walking.” Other doctors were against starting Alderson on treatment because of his age and the severity of his cancer, but the couple didn’t want to give up.
Alderson started with 10 rounds of radiation therapy. Initially, his carcinoembryonic antigen (CEA), a marker for tumor activity, was significantly elevated at 480 nanograms per milliliter (ng/mL).
One month later, he started chemotherapy. After that, his CEA levels skyrocketed to 1,498 ng/mL. By the time Alderson started treatment, his colon cancer had metastasized and spread to his liver. The latter had 25 tumors.
In an interview with The Cancer Box, a cancer diagnosis blog, Alderson shared that he started researching preventative medication, which led him to ivermectin.
Further research suggested that ivermectin could likely enhance the effectiveness of his chemotherapy and radiation therapy, with data also showing that the medication was relatively safe.
In February 2021, Alderson started taking ivermectin. Ten days later, his CEA levels had gone down to 184 ng/mL. By April 7, it was 20.7, and by April 21, it had dropped to only 13.9 ng/mL.
Thanks to your generous support, we are building the infrastructure of human freedom and actively donating our technology to independent publishers, authors and home schooling organizations. Learn about our game-changing non-commercial AI project here. Support our ongoing efforts to preserve and enhance human knowledge by shopping at HealthRangerStore.com.
By midsummer, Alderson’s CEA levels had decreased into the normal range. Out of the 25 tumors in his liver, only three remained. (Related: FDA is NOT a physician: Appeals court sides with doctors on the use of ivermectin for COVID-19.)
Alderson lived for two more blessed years before succumbing to liver failure due to the progression of his three remaining liver tumors.
His wife was grateful, adding that his survival beyond his grim prognosis was because of his success with ivermectin and fluorouracil, a chemotherapy drug.
Ivermectin has several anti-cancer effects
Dr. Alfonso Dueñas-González, an oncologist and senior researcher at the National Autonomous University of Mexico, explained that there are at least nine “perfectly defined cancer targets affected by ivermectin.”
The first reports of ivermectin’s anti-cancer properties were released in 1995. At the time, two French researchers discovered that the Nobel Prize-winning anti-parasite drug ivermectin could reverse multidrug resistance in tumors.
Ivermectin targets tumor stem cells, a driver of cancer tumors and relapses, and promotes cancer death. The drug was also found to boost the effects of chemo and radiation therapy.
Read more:
